DE2732437C3 - Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung - Google Patents

Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung

Info

Publication number
DE2732437C3
DE2732437C3 DE2732437A DE2732437A DE2732437C3 DE 2732437 C3 DE2732437 C3 DE 2732437C3 DE 2732437 A DE2732437 A DE 2732437A DE 2732437 A DE2732437 A DE 2732437A DE 2732437 C3 DE2732437 C3 DE 2732437C3
Authority
DE
Germany
Prior art keywords
haptoglobin
reaction
preparation
bifunctional compound
fibrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2732437A
Other languages
German (de)
English (en)
Other versions
DE2732437B2 (de
DE2732437A1 (de
Inventor
Satoshi Katano Funakoshi
Takao Toyonaka Oomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of DE2732437A1 publication Critical patent/DE2732437A1/de
Publication of DE2732437B2 publication Critical patent/DE2732437B2/de
Application granted granted Critical
Publication of DE2732437C3 publication Critical patent/DE2732437C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE2732437A 1976-08-27 1977-07-18 Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung Expired DE2732437C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10276376A JPS5329908A (en) 1976-08-27 1976-08-27 Immobilized haptoglobin preparation

Publications (3)

Publication Number Publication Date
DE2732437A1 DE2732437A1 (de) 1978-03-02
DE2732437B2 DE2732437B2 (de) 1979-02-01
DE2732437C3 true DE2732437C3 (de) 1979-09-27

Family

ID=14336221

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2732437A Expired DE2732437C3 (de) 1976-08-27 1977-07-18 Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung

Country Status (12)

Country Link
US (1) US4113853A (member.php)
JP (1) JPS5329908A (member.php)
BE (1) BE857021A (member.php)
CA (1) CA1085291A (member.php)
CH (1) CH632930A5 (member.php)
DE (1) DE2732437C3 (member.php)
ES (1) ES460861A1 (member.php)
FR (1) FR2362861A1 (member.php)
GB (1) GB1551646A (member.php)
LU (1) LU77802A1 (member.php)
NL (1) NL176637C (member.php)
SE (1) SE446430B (member.php)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462989A (en) * 1981-05-04 1984-07-31 Evreka, Inc. Method and agents for arresting infection
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
ATE302019T1 (de) * 1997-02-28 2005-09-15 Univ California Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
RU2337705C2 (ru) * 2003-01-29 2008-11-10 Нортфилд Лэборэтериз, Инк. Растворы полимеризованного гемоглобина с пониженным количеством тетрамера и способ их получения
US20070196810A1 (en) * 2006-01-24 2007-08-23 Northfield Laboratories Inc. Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells

Also Published As

Publication number Publication date
LU77802A1 (member.php) 1977-10-25
ES460861A1 (es) 1978-04-16
CH632930A5 (de) 1982-11-15
JPS5523806B2 (member.php) 1980-06-25
NL176637C (nl) 1985-05-17
FR2362861B1 (member.php) 1980-02-15
FR2362861A1 (fr) 1978-03-24
NL176637B (nl) 1984-12-17
SE7707889L (sv) 1978-02-28
DE2732437B2 (de) 1979-02-01
JPS5329908A (en) 1978-03-20
US4113853A (en) 1978-09-12
BE857021A (fr) 1977-11-14
SE446430B (sv) 1986-09-15
GB1551646A (en) 1979-08-30
CA1085291A (en) 1980-09-09
NL7708024A (nl) 1978-03-01
DE2732437A1 (de) 1978-03-02

Similar Documents

Publication Publication Date Title
DE2827109C2 (de) Verfahren und Vorrichtung zur Abtrennung von organischen Verbindungen von Plasmaproteinen des Blutes
DE68920671T2 (de) Ein mit Hirudin, deren Analoge oder deren Fragmente beschichtetes bioverträgliches und thromboresistentes Material und seine Herstellung.
DE69713667T2 (de) Medizinische Vorrichtung zur extrakorporalen Blut-oder Blutplasmabehandlung und Herstellungsverfahren für diese Vorrichtung
DE69632476T2 (de) Behandlung von dilatierte kardiomyopathie durch entfernung von autoantikoerpern
DE2732437C3 (de) Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung
DE3039566A1 (de) Verfahren zur reinigung von interferon
DE69624914T2 (de) Vorrichtung und verfahren für die biospezifische entfernung von heparin
DE112005001901T5 (de) Einfangen und entfernen von Biomolekülen aus Körperflüssigkeiten unter Verwendung von partiellen molekularen Abdrücken
EP0739630A2 (de) Verfahren und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
DE3786832T2 (de) Verfahren zur Herstellung von Immunoglobulinzubereitungen für intravenöse Injektion.
DE2832536A1 (de) Kuenstliches medizinisches material mit gerinnungshemmender wirkung
DE3150318C2 (de) "Verfahren zur Herstellung eines Polysaccharidderivats des Fibrinolysins"
DD298110A5 (de) Verfahren zur herstellung eines konzentrats des blutgerinnungsfaktor-viii-von-willebrand-faktor-komplexes aus gesamten plasma
DE69224517T2 (de) Trägermaterial und biokompatibler Anionenanstauscher
DE2624815B2 (de) Herstellung einer injizierbaren, stromafreien und von Plasmaproteinen freien Hämoglobinlösung
DE10011481A1 (de) Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin, Verwendung des Adsorbens zur Herstellung eines Adsorbers und Adsorber mit dem Adsorbens
EP1132129B1 (de) Verfahren zum Herstellen eines Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin, Adsorbens und Verwendung des Adsorbens zur Herstellung eines Adsorbers
EP1326893A2 (de) Bikunin enthaltende plasmafraktion, verfahren zu ihrer herstellung und ihrer verwendung
CH643861A5 (de) Verfahren zum reinigen eines gamma-globulinderivats.
DE2428955C3 (de) Verfahren zur Abtrennung der enzymatischen Komponente mit in vivo antikoagulierender und in vitro koagulierender Wirkung aus dem Gift der Schlange Ancistrodon rhodostoma und daraus hergestellte Mittel
DE2061009A1 (de) Verfahren zur Fixierung von Polymeren
DE4428056A1 (de) Verwendung von Mikropartikelpräparationen zur Eliminierung gelöster, nicht nierengängiger Substanzen aus dem Blut
DE3145007A1 (de) Immobilisierte biologisch aktive substanzen und ihre verwendung
DE3039855C2 (member.php)
EP0975671B1 (de) VERFAHREN ZUR CHROMATOGRAPHISCHEN REINIGUNG BZW. FRAKTIONIERUNG VON VON WILLEBRAND-FAKTOR AUS EINEM vWF-HÄLTIGEN AUSGANGSMATERIAL

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
C3 Grant after two publication steps (3rd publication)
8328 Change in the person/name/address of the agent

Free format text: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee